Interdisziplinäres, kollaboratives D-A-CH Konsensus-Statement zur Diagnostik und Behandlung von Myalgischer Enzephalomyelitis/Chronischem Fatigue-Syndrom

[1]  Z. Al‐Aly,et al.  Long Covid and Impaired Cognition — More Evidence and More Work to Do , 2024, The New England journal of medicine.

[2]  M. Faghy,et al.  Using cardiorespiratory fitness assessment to identify pathophysiology in long COVID - Best practice approaches. , 2024, Progress in cardiovascular diseases.

[3]  P. Reuken,et al.  Long COVID is associated with severe cognitive slowing: a multicentre cross-sectional study , 2024, EClinicalMedicine.

[4]  M. Puhan,et al.  Persistent complement dysregulation with signs of thromboinflammation in active Long Covid , 2024, Science.

[5]  W. Sha,et al.  Risks of digestive diseases in long COVID: evidence from a population-based cohort study , 2024, BMC medicine.

[6]  Bauke V. Schomakers,et al.  Muscle abnormalities worsen after post-exertional malaise in long COVID , 2024, Nature communications.

[7]  D. Ret,et al.  Immunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome , 2024, Journal of clinical medicine.

[8]  Karen Giménez-Orenga,et al.  Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives , 2024, Journal of clinical medicine.

[9]  Daniel B R Hattesohl,et al.  Why the Psychosomatic View on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Inconsistent with Current Evidence and Harmful to Patients , 2023, Medicina.

[10]  W. Tate,et al.  A pilot study on the immune cell proteome of long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis/chronic fatigue syndrome , 2023, Scientific reports.

[11]  M. Wormgoor,et al.  Focus on post-exertional malaise when approaching ME/CFS in specialist healthcare improves satisfaction and reduces deterioration , 2023, Frontiers in neurology.

[12]  L. Habermann-Horstmeier,et al.  Systemisches Denken, subjektive Befunde und das diagnostische „Schubladendenken“ bei ME/CFS – Eine vorwiegend qualitative Public-Health-Studie aus Patientensicht , 2023, DMW - Deutsche Medizinische Wochenschrift.

[13]  L. Habermann-Horstmeier,et al.  [Implications of the quality of the doctor-patient relationship on health in adult ME/CFS patients. A qualitative public health study from a patien perspective]. , 2023, MMW Fortschritte der Medizin.

[14]  A. Vahratian,et al.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Adults: United States, 2021-2022. , 2023, NCHS data brief.

[15]  W. Sato,et al.  Brain-regional characteristics and neuroinflammation in ME/CFS patients from neuroimaging: A systematic review and meta-analysis. , 2023, Autoimmunity reviews.

[16]  L. Melby,et al.  ‘We have no services for you… so you have to make the best out of it’: A qualitative study of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients’ dissatisfaction with healthcare services , 2023, Health expectations : an international journal of public participation in health care and health policy.

[17]  S. Blitshteyn.  Dysautonomia, Hypermobility Spectrum Disorders and Mast Cell Activation Syndrome as Migraine Comorbidities , 2023, Current Neurology and Neuroscience Reports.

[18]  R. Badawi,et al.  First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody , 2023, Science advances.

[19]  D. Saylor,et al.  Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition , 2023, Journal of the Neurological Sciences.

[20]  Ravindra Ganesh,et al.  Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. , 2023, Mayo Clinic proceedings.

[21]  C. Scheibenbogen,et al.  Pediatric and adult patients with ME/CFS following COVID-19: A structured approach to diagnosis using the Munich Berlin Symptom Questionnaire (MBSQ) , 2023, medRxiv.

[22]  J. Behrens,et al.  Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort , 2023, EClinicalMedicine.

[23]  D. Kell,et al.  Accelerating discovery: A novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model , 2023, Heliyon.

[24]  C. Scheibenbogen,et al.  One-year follow-up of young people with ME/CFS following infectious mononucleosis by Epstein-Barr virus , 2023, medRxiv.

[25]  K. Kurz,et al.  Leitlinie S1 für das Management postviraler Zustände am Beispiel Post-COVID-19 , 2023, Wiener klinische Wochenschrift.

[26]  Ursula Costa.  Leitfaden für das Management von Folgen viraler Erkrankung mit SARS-CoV-2 aus Sicht der Ergotherapie , 2023, Wiener klinische Wochenschrift.

[27]  C. Scheibenbogen,et al.  Die Übersicht zur aktuellen Evidenz ignoriert die aktuelle Evidenz , 2023, Der Nervenarzt.

[28]  F. Knolle,et al.  Fighting Post-COVID and ME/CFS – development of curative therapies , 2023, Frontiers in Medicine.

[29]  A. Komaroff,et al.  ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature , 2023, Frontiers in Medicine.

[30]  Derek J Van Booven,et al.  Sex-Dependent Transcriptional Changes in Response to Stress in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Project , 2023, International journal of molecular sciences.

[31]  Kerri M. Smith.  Women’s health research lacks funding — these charts show how , 2023, Nature.

[32]  Leonard A. Jason,et al.  Do diagnostic criteria for ME matter to patient experience with services and interventions? Key results from an online RDS survey targeting fatigue patients in Norway , 2023, Journal of health psychology.

[33]  J. Rossman,et al.  Hypothesis: inflammatory acid-base disruption underpins Long Covid , 2023, Frontiers in Immunology.

[34]  E. Grevet,et al.  Successful Treatment of Post-COVID-19 ADHD-like Syndrome: A Case Report , 2023, Journal of attention disorders.

[35]  X. Mao,et al.  Recovery from Exercise in Persons with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) , 2023, Medicina.

[36]  S. Vernon,et al.  Multi-'omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients. , 2023, Cell host & microbe.

[37]  C. Francomano,et al.  Clinician-associated traumatization from difficult medical encounters: Results from a qualitative interview study on the Ehlers-Danlos Syndromes , 2023, SSM. Qualitative research in health.

[38]  R. Tschopp,et al.  Health system support among patients with ME/CFS in Switzerland , 2023, Journal of Taibah University Medical Sciences.

[39]  Natascha Brigo,et al.  Urine Metabolite Analysis to Identify Pathomechanisms of Long COVID: A Pilot Study , 2023, International journal of tryptophan research : IJTR.

[40]  A. Arnsten,et al.  Clinical experience with the α2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in “Long-COVID19” , 2022, Neuroimmunology Reports.

[41]  C. Scheibenbogen,et al.  [When COVID does not heal: post-COVID courses with fatigue and exercise intolerance]. , 2022, Deutsche medizinische Wochenschrift.

[42]  J. Fortrat,et al.  Factors Influencing the Prognosis of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome , 2022, Diagnostics.

[43]  A. Truini,et al.  The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ) for identifying pure small fiber neuropathy , 2022, Journal of the peripheral nervous system : JPNS.

[44]  J. Silver,et al.  Multi‐Disciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Autonomic Dysfunction in Patients with Post‐Acute Sequelae of SARS‐CoV‐2 Infection (PASC) , 2022, PM & R : the journal of injury, function, and rehabilitation.

[45]  T. Harrer,et al.  Post-COVID-19 Syndrome: Retinal Microcirculation as a Potential Marker for Chronic Fatigue , 2022, medRxiv.

[46]  D. Kell,et al.  The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications , 2022, The Biochemical journal.

[47]  C. D. Dela Cruz,et al.  Distinguishing features of long COVID identified through immune profiling , 2022, Nature.

[48]  D. Kell,et al.  Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) , 2022, Cardiovascular Diabetology.

[49]  Yike Jin,et al.  Craniocervical Instability in Patients With Ehlers-Danlos Syndrome: Controversies in Diagnosis and Management. , 2022, The spine journal : official journal of the North American Spine Society.

[50]  C. Scheibenbogen,et al.  Post-COVID-Syndrom mit Fatigue und Belastungsintoleranz: Myalgische Enzephalomyelitis bzw. Chronisches Fatigue-Syndrom , 2022, Die Innere Medizin.

[51]  S. Efrati,et al.  Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial , 2022, Scientific Reports.

[52]  Michael Graham,et al.  Repeated maximal exercise tests of peak oxygen consumption in people with myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review and meta-analysis , 2022, Fatigue: Biomedicine, Health & Behavior.

[53]  J. Lambert,et al.  Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study , 2022, Brain, Behavior, & Immunity - Health.

[54]  H. Tankisi,et al.  Myopathy as a cause of fatigue in long‐term post‐COVID‐19 symptoms: Evidence of skeletal muscle histopathology , 2022, European journal of neurology.

[55]  L. Abid,et al.  Sulodexide Significantly Improves Endothelial Dysfunction and Alleviates Chest Pain and Palpitations in Patients With Long-COVID-19: Insights From TUN-EndCOV Study , 2022, Frontiers in Cardiovascular Medicine.

[56]  M. Tremblay,et al.  The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure , 2022, Frontiers in Cellular Neuroscience.

[57]  A. Iwasaki,et al.  Unexplained post-acute infection syndromes , 2022, Nature Medicine.

[58]  W. Xiao,et al.  Neurovascular Dysregulation and Acute Exercise Intolerance in ME/CFS: A Randomized, Placebo-Controlled Trial of Pyridostigmine. , 2022, Chest.

[59]  Laura Schneider,et al.  Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults , 2022, Frontiers in Neurology.

[60]  Sanjay Cheema,et al.  The prevalence of headache disorders in Postural Tachycardia Syndrome: A systematic review and meta-analysis of the literature , 2022, Cephalalgia : an international journal of headache.

[61]  M. Maurer,et al.  Idiopathic mast cell activation syndrome is more often suspected than diagnosed—A prospective real‐life study , 2022, Allergy.

[62]  Mohammed F. Islam,et al.  Evaluating case diagnostic criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): toward an empirical case definition , 2022, Disability and rehabilitation.

[63]  M. Fehlings,et al.  Craniocervical Instability in Ehlers-Danlos Syndrome—A Systematic Review of Diagnostic and Surgical Treatment Criteria , 2022, Global spine journal.

[64]  Jin-Mann S. Lin,et al.  Physiological assessment of orthostatic intolerance in chronic fatigue syndrome , 2022, Journal of translational medicine.

[65]  M. Hainselin,et al.  Systematic review and meta-analysis of cognitive impairment in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) , 2022, Scientific Reports.

[66]  Rashika Bansal,et al.  COVID-19 and chronic fatigue syndrome: An endocrine perspective , 2021, Journal of Clinical & Translational Endocrinology.

[67]  J. Lafuente,et al.  The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker? , 2021, Journal of Translational Medicine.

[68]  P. Novak,et al.  Mast Cell Disorders Are Associated with Decreased Cerebral Blood Flow And Small Fiber Neuropathy. , 2021, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[69]  J. Sachau,et al.  Small-Fiber-Neuropathien , 2021, DGNeurologie.

[70]  J. Montoya,et al.  Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome , 2021, Healthcare.

[71]  M. Stingl,et al.  Evaluation of Immune Dysregulation in an Austrian Patient Cohort Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome , 2021, Biomolecules.

[72]  Ilene S Ruhoy,et al.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. , 2021, Mayo Clinic proceedings.

[73]  N. Speight,et al.  ME/CFS: Past, Present and Future , 2021, Healthcare.

[74]  C. Scheibenbogen,et al.  Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany , 2021, Medicina.

[75]  Lily Chu,et al.  Identifying and Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome , 2021, Healthcare.

[76]  D. Kell,et al.  Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin , 2021, Cardiovascular Diabetology.

[77]  C. Scheibenbogen,et al.  European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe , 2021, Medicina.

[78]  C. Scheibenbogen,et al.  Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS , 2021, Journal of translational medicine.

[79]  W. Weir,et al.  Life-Threatening Malnutrition in Very Severe ME/CFS , 2021, Healthcare.

[80]  L. Hodges,et al.  Effects of Post-Exertional Malaise on Markers of Arterial Stiffness in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome , 2021, International journal of environmental research and public health.

[81]  I. Sachmechi,et al.  The association between COVID-19 and type 1 diabetes mellitus: A systematic review , 2021, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[82]  A. Oaklander,et al.  Insights from Invasive Cardiopulmonary Exercise Testing of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. , 2021, Chest.

[83]  A. Subramanian,et al.  Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole , 2021, Journal of translational medicine.

[84]  A. Komaroff,et al.  Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? , 2021, Frontiers in Medicine.

[85]  A. Drewes,et al.  Study protocol for a multicentre, randomised, parallel group, sham-controlled clinical trial investigating the effect of transcutaneous vagal nerve stimulation on gastrointestinal symptoms in people with diabetes complicated with diabetic autonomic neuropathy: the DAN-VNS Study , 2021, BMJ Open.

[86]  A. Finlay,et al.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Major Impact on Lives of Both Patients and Family Members , 2021, Medicina.

[87]  Eun-su Jang,et al.  The Prospects of the Two-Day Cardiopulmonary Exercise Test (CPET) in ME/CFS Patients: A Meta-Analysis , 2020, Journal of clinical medicine.

[88]  A. Esmail,et al.  Myalgic encephalomyelitis (or encephalopathy) / chronic fatigue syndrome: diagnosis and management: Involving adults with severe ME/CFS symptomsin developing a NICE guideline on Myalgic encephalomyelitis/Chronic fatigue syndrome:diagnosis and management , 2020 .

[89]  A. Michos,et al.  Signs of Intracranial Hypertension, Hypermobility, and Craniocervical Obstructions in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome , 2020, Frontiers in Neurology.

[90]  L. Jason,et al.  Research update: The relation between ME/CFS disease burden and research funding in the USA. , 2020, Work.

[91]  C. Scheibenbogen,et al.  A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors. , 2020, Autoimmunity reviews.

[92]  Eun-su Jang,et al.  Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) , 2020, Journal of Translational Medicine.

[93]  F. Verheugt,et al.  Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography , 2020, Clinical neurophysiology practice.

[94]  L. Jason,et al.  The Prevalence of Pediatric Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in a Community-Based Sample , 2020, Child & Youth Care Forum.

[95]  M. Beutel,et al.  Measurement invariance, validation and normative data of the Jenkins Sleep Scale-4 (JSS-4) in the German general population across the life span. , 2020, Journal of psychosomatic research.

[96]  H. van Marwijk,et al.  Low-dose naltrexone as a treatment for chronic fatigue syndrome , 2020, BMJ Case Reports.

[97]  C. Lavigne,et al.  Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome , 2019, Scientific Reports.

[98]  P. Salkovskis,et al.  Prevalence and treatment of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and co-morbid severe health anxiety , 2019, International journal of clinical and health psychology : IJCHP.

[99]  J. Bernstein,et al.  AAAAI Mast Cell Disorders Committee Work Group Report: Mast Cell Activation Syndrome (MCAS) Diagnosis and Management. , 2019, The Journal of allergy and clinical immunology.

[100]  M. Vink,et al.  Work Rehabilitation and Medical Retirement for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. A Review and Appraisal of Diagnostic Strategies , 2019, Diagnostics.

[101]  M. Hann,et al.  Myalgic encephalomyelitis/chronic fatigue syndrome patients’ reports of symptom changes following cognitive behavioural therapy, graded exercise therapy and pacing treatments: Analysis of a primary survey compared with secondary surveys , 2019, Journal of health psychology.

[102]  B. Lidbury,et al.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review , 2019, Diagnostics.

[103]  P. Iversen,et al.  Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis/chronic fatigue syndrome , 2019, Physiological reports.

[104]  T. Clark,et al.  Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study , 2019, Diagnostics.

[105]  M. Triggiani,et al.  Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome. , 2019, The journal of allergy and clinical immunology. In practice.

[106]  K. Rowe.  Long Term Follow up of Young People With Chronic Fatigue Syndrome Attending a Pediatric Outpatient Service , 2019, Front. Pediatr..

[107]  D. Bennett,et al.  Prevalence of Obstructive Sleep Apnea in Joint Hypermobility Syndrome: A Systematic Review and Meta-Analysis. , 2019, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[108]  Peter Tyrer,et al.  Innovations and changes in the ICD‐11 classification of mental, behavioural and neurodevelopmental disorders , 2019, World psychiatry : official journal of the World Psychiatric Association.

[109]  L. Jason,et al.  The Development of the DePaul Symptom Questionnaire: Original, Expanded, Brief, and Pediatric Versions , 2018, Front. Pediatr..

[110]  L. Jason,et al.  Effects of unsupportive social interactions, stigma, and symptoms on patients with myalgic encephalomyelitis and chronic fatigue syndrome. , 2018, Journal of community psychology.

[111]  L. Jason,et al.  A Brief Questionnaire to Assess Post-Exertional Malaise , 2018, Diagnostics.

[112]  D. A. Janneke Dijck-Brouwer,et al.  Higher Prevalence of “Low T3 Syndrome” in Patients With Chronic Fatigue Syndrome: A Case–Control Study , 2018, Front. Endocrinol..

[113]  H. Volk,et al.  Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME , 2018, PloS one.

[114]  L. Nacul,et al.  Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls , 2018, PharmacoEconomics - Open.

[115]  K. Rowe,et al.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer , 2017, Front. Pediatr..

[116]  L. Jason,et al.  Mortality in patients with myalgic encephalomyelitis and chronic fatigue syndrome , 2016, Fatigue : biomedicine, health & behavior.

[117]  E. Cvejic,et al.  Cognitive Dysfunction in Chronic Fatigue Syndrome: a Review of Recent Evidence , 2016, Current Rheumatology Reports.

[118]  J. Newton,et al.  Understanding Muscle Dysfunction in Chronic Fatigue Syndrome , 2016, Journal of aging research.

[119]  L. Marshall,et al.  Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians , 2015, Reviews on environmental health.

[120]  P. Magnus,et al.  Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. , 2015, Vaccine.

[121]  N. Unterwalder,et al.  Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome. , 2015, Human immunology.

[122]  K. D. Petersen,et al.  The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) , 2015, PloS one.

[123]  P. Magnus,et al.  Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008–2012 , 2014, BMC Medicine.

[124]  B. Löwe,et al.  The somatic symptom scale-8 (SSS-8): a brief measure of somatic symptom burden. , 2014, JAMA internal medicine.

[125]  C. Snell,et al.  Discriminative Validity of Metabolic and Workload Measurements for Identifying People With Chronic Fatigue Syndrome , 2013, Physical Therapy.

[126]  A. Frances.  The new somatic symptom disorder in DSM-5 risks mislabeling many people as mentally ill , 2013, BMJ.

[127]  Colin R. Martin,et al.  The Neuropsychiatric and Neuropsychological Features of Chronic Fatigue Syndrome: Revisiting the Enigma , 2013, Current Psychiatry Reports.

[128]  L. Jason,et al.  Energy conservation/envelope theory interventions , 2013, Fatigue : biomedicine, health & behavior.

[129]  J. Warren,et al.  Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults , 2012, Cancer.

[130]  L. Jason,et al.  Pacing as a strategy to improve energy management in myalgic encephalomyelitis/chronic fatigue syndrome: a consensus document , 2012, Disability and rehabilitation.

[131]  J. Sterne,et al.  Unidentified Chronic Fatigue Syndrome/myalgic encephalomyelitis (CFS/ME) is a major cause of school absence: surveillance outcomes from school-based clinics , 2011, BMJ Open.

[132]  I. Mena,et al.  Myalgic encephalomyelitis: International Consensus Criteria , 2011, Journal of internal medicine.

[133]  M. Molokhia,et al.  The functional status and well being of people with myalgic encephalomyelitis/chronic fatigue syndrome and their carers , 2011, BMC public health.

[134]  G. Bleijenberg,et al.  Adolescent Chronic Fatigue Syndrome: Prevalence, Incidence, and Morbidity , 2011, Pediatrics.

[135]  L. Afrin,et al.  Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options , 2011, Journal of hematology & oncology.

[136]  R. J. Bakker,et al.  Adolescent chronic fatigue syndrome: a follow-up study. , 2010, Archives of pediatrics & adolescent medicine.

[137]  C. Snell,et al.  Conceptual Model for Physical Therapist Management of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis , 2010, Physical Therapy.

[138]  T. Staufenbiel,et al.  Messung chronischer Erschöpfung – Teststatistische Prüfung der Fatigue Skala (FS) , 2010 .

[139]  A. Kong,et al.  Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. , 2009, Archives of internal medicine.

[140]  J. Sterne,et al.  Association between school absence and physical function in paediatric chronic fatigue syndrome/myalgic encephalopathy , 2008, Archives of Disease in Childhood.

[141]  B. Carruthers.  Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works , 2006, Journal of Clinical Pathology.

[142]  Karin Dahlman-Wright,et al.  Reduced levels of oestrogen receptor β mRNA in Swedish patients with chronic fatigue syndrome , 2006, Journal of Clinical Pathology.

[143]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[144]  W. Reeves,et al.  Factors influencing the diagnosis of chronic fatigue syndrome. , 2004, Archives of internal medicine.

[145]  R. Taylor.  Death of neurasthenia and its psychological reincarnation , 2001, British Journal of Psychiatry.

[146]  R. Abs,et al.  Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome , 2000, Clinical endocrinology.

[147]  N. Larocca,et al.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. , 1989, Archives of neurology.

[148]  K. Rajaratnam,et al.  Prevalence of symptoms, comorbidities, �brin amyloid microclots and platelet pathology in individuals with Long COVID/ Post-Acute Sequelae of COVID-19 (PASC) , 2022 .

[149]  Consultant Microbiologist,et al.  Long Term Sickness Absence due to ME / CFS in UK Schools : An Epidemiological Study With Medical and Educational Implications , 2008 .